Stock listing

Tokyo:4586 Medrx Co., Ltd. (メドレックス) 株価

Follow Medrx Co., Ltd. into a list and get an email when it puts out news.

Medrx Co., Ltd. logo
Ticker
Tokyo:4586
Asset type
Stock
Exchange
Tokyo
Currency
JPY

What changed lately

Latest news

Results of MRX-7MLL Phase I a Clinical Trial

May 23, 2025

Summary of Business Results for the First Quarter Ended March 31, 2025 (Consolidated)

May 20, 2025

FDA Acceptance of New Drug Application for MRX-5LBT (“Lydolyte”)

Apr 2, 2025

Summary of Business Results for the Third Quarter Ended September 30, 2024 (Consolidated)

Nov 8, 2024

Start of MRX-7MLL Phase I a Clinical Trial

Oct 28, 2024

H1 FY2024 Business Highlight & Financial Results

Aug 21, 2024

Summary of Business Results for the Second Quarter Ended June 30, 2024 (Consolidated)

Aug 9, 2024

Receipt of Complete Response Letter for MRX-5LBT

Jul 11, 2024

Notice of revised forecasts of consolidated financial results

Apr 23, 2024

Prospect of NDA Re-Submission for MRX-5LBT

Oct 10, 2023

All Medrx Co., Ltd. news

Decks

Medrx Co., Ltd. on 6ix

News releases
14 in all · newest May 23, 2025 · oldest 2022
Decks
3 decks · latest Feb 17, 2026

Log in to ask 6ix AI your own questions about Medrx Co., Ltd.